RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |
| Cercano Management LLC | 978,051 | $7,540,773 | 0.31% |
| Comprehensive Financial Management LLC | 1,109,395 | $8,553,435 | 0.28% |
| HAMILTON LANE ADVISORS LLC | 96,474 | $744 | 0.27% |
| Jackson Creek Investment Advisors LLC | 77,011 | $594 | 0.26% |
| ARK Investment Management | 3,099,490 | $23,897,068 | 0.21% |
| Baillie Gifford | 24,820,850 | $191,368,754 | 0.20% |
| Laurion Capital Management LP | 4,825,735 | $37,206,417 | 0.17% |
| Cypress Point Wealth Management, LLC | 14,219 | $109,628 | 0.17% |
| GoalFusion Wealth Management, LLC | 20,000 | $166,600 | 0.13% |
| Bienville Capital Management, LLC | 56,876 | $438,514 | 0.13% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q4 2022. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.